Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00849394 · ClinicalTrials.gov registry record
Evaluation of Protein in the Urine in Patients Receiving Bevacizumab
A clinical trial, sponsored by North Texas Veterans Healthcare System.
- Completed
- Registry status
- 106
- Enrollment target
NCT00849394: Completed study, sponsored by North Texas Veterans Healthcare System.
NCT00849394 is a clinical trial that has completed, run by North Texas Veterans Healthcare System. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00849394 has completed, sponsored by North Texas Veterans Healthcare System.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
This is a clinical research study to look at the incidence of proteinuria (a condition in which urine contains an abnormal amount of protein) caused by shortened infusions (given into the vein over 10 or 15 minutes) of bevacizumab (a medication prescribed for colon, lung, or breast cancer). There are currently no published studies or clinical data looking at how safe shortened infusions of bevacizumab are in relationship to the side effect of proteinuria. We hypothesis that shortened infusions of bevacizumab will result in an increased risk for proteinuria compared to the standard infusions of this agent.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2007-11 |
| Est. Completion | 2012-06 |
What the finished NCT00849394 record still lists
NCT00849394 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00849394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00849394 about?
NCT00849394 is a clinical study titled "Evaluation of Protein in the Urine in Patients Receiving Bevacizumab". This is a clinical research study to look at the incidence of proteinuria (a condition in which urine contains an abnormal amount of protein) caused by shortened infusions (given into the vein over 10 or 15 minutes) of bevacizumab (a medication prescribed for colon, lung, or breast cancer). There ar...
What is the current status of trial NCT00849394?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2007-11. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT00849394?
This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia